BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Caspofungin

A cyclic lipopeptide echinocandin and beta-(1,3)-D-glucan synthase inhibitor that is used to treat internal or systemic MYCOSES.

299+ PubMed studies analyzed · 21 RCTs · Evidence Score: 48.8

Research Domains

Caspofungin has been studied across 13 research domains including 🫘 Kidney, 🔬 Oncology, 🫁 Liver & Detox, 🫁 Respiratory, 🛡️ Immunity. The primary research focus is 🫘 Kidney with 5% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Caspofungin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Oxyfedrine
3 shared targets
Prilocaine
2 shared targets
nomifensine
2 shared targets
methylphenidate
2 shared targets
nisoxetine
2 shared targets
milnacipran
2 shared targets
tenamfetamine
2 shared targets
midomafetamine
2 shared targets
desvenlafaxine
2 shared targets
esreboxetine
2 shared targets
Loading evidence profile...

This evidence profile for Caspofungin is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.